Yahoo
HKSE - Delayed Quote HKD

TransThera Sciences (Nanjing), Inc. (2617.HK)

8.145 +0.060 (+0.74%)
As of 11:59:50 AM GMT+8. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
Total Revenue
35,455 0 0 1,181
Cost of Revenue
0 0 0 0
Gross Profit
35,455 0 0 1,181
Selling, General and Administrative Expenses
-50,366 -54,777 -47,737 -36,203
Research and Development Expenses
-258,259 -246,761 -244,004 -344,475
Depreciation, Amortization and Depletion
-2,569 -- -2,569 -3,016
Other Income/Expense, Operating
10,269 1,356 5,061 10,329
Operating Income/Expenses
-298,356 -300,182 -286,680 -373,365
Total Operating Profit/Loss
-262,901 -300,182 -286,680 -372,184
Total Net Finance Income/Expense
8,857 4,786 1,970 11,914
Net Investment Income
-14,357 -451 10,280 17,105
Irregular Income/Expenses
47 -1 -31 -9
Other Income/Expense, Non-Operating
-209 -116 -149 -220
Non-Operating Income/Expenses, Total
-5,662 4,218 12,070 28,790
Pretax Income
-268,563 -295,964 -274,610 -343,394
Provision for Income Tax
0 0 0 0
Net Income from Continuing Operations
-268,563 -295,964 -274,610 -343,394
Net Income after Extraordinary Items and Discontinued Operations
-268,563 -295,964 -274,610 -343,394
Net Income after Non-Controlling/Minority Interests
-268,563 -295,964 -274,610 -343,394
Net Income Available to Common Stockholders
-268,563 -295,964 -274,610 -343,394
Diluted Net Income Available to Common Stockholders
-268,563 -295,964 -274,610 -343,394
Basic EPS
-0.68 -0.76 -0.69 -0.87
Diluted EPS
-0.68 -0.76 -0.69 -0.87
Basic Weighted Average Shares Outstanding
399,306.225 389,654.858 396,897.633 396,897.633
Diluted Weighted Average Shares Outstanding
399,306.225 389,654.858 396,897.633 396,897.633
Income Statement, Supplemental
EBIT
-277,420 -300,750 -276,580 -355,308
EBITDA
-273,068 -295,723 -270,143 -347,904
Normalized EBITDA
-249,348 -282,295 -264,836 -355,067
Normalized Income
-244,843 -282,536 -269,303 -350,557
12/31/2023 - 6/23/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: